Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder.
Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica.
A correlation study between multiple sclerosis and type 1 diabetes incidences and geochemical data in Europe.
Poppers toxic maculopathy misdiagnosed as atypical optic neuritis.
Brain atrophy at onset and physical disability in multiple sclerosis.
Helicobacter pylori serology in autoimmune diseases - fact or fiction?
Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica.
Jacksonian seizure as the relapse symptom of multiple sclerosis.
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People.
Efficacy and safety of laquinimod in multiple sclerosis: current status.
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.
Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice.
Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon beta.
Interferon beta assessment in non-Chinese and Chinese subjects: Pharmacokinetics and pharmacodynamic activity of an endogenous cytokine are not race dependent.
Training of Respiratory Muscles in Patients With Multiple Sclerosis: A Systematic Review.
Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.
An epidemiological study of neuromyelitis optica in Isfahan.
Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
Histological characterization and quantification of cellular events following neural and fibroblast(-like) stem cell grafting in healthy and demyelinated CNS tissue.
Remotely-supervised transcranial direct current stimulation (tDCS) for clinical trials: guidelines for technology and protocols.
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis.
Multiple sclerosis databases: present and future.
Hughes syndrome and Multiple sclerosis.
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.
Pages
« first
‹ previous
…
314
315
316
317
318
319
320
321
322
…
next ›
last »